Desktop Site
|
18 Apr 24 | 15:15
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
72,641.71
-301.97
-0.41 %
Corporate Announcement
Security Code
524804
Company
Aurobindo Pharma Ltd
Exchange Received Time
19/02/2020 08:46:00
Exchange Disseminated Time
19/02/2020 08:46:07
Time Taken
00:00:07
Update On US FDA Inspection At Our Unit IV - Reg., |
2/19/2020 8:46:01 AM
Further to our intimation dated November 13, 2019 with regard to the USFDA inspection of Unit IV, a general injectable formulation manufacturing facility of the Company, we would like to inform you that the Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAI) status from USFDA.
Please take the above information on record.
Attachment
<< Back
Recently Viewed